Generate Biomedicines, Inc.
SEC CIK 2100782 · GENB · last insider filing 2026-03-12
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Nally Michael | Director · Chief Executive Officer | filed 2026 - 2026 |
| Afeyan Noubar | Director | filed 2026 - 2026 |
| Fanucci Marsha | Director | filed 2026 - 2026 |
| Simonian Nancy A | Director | filed 2026 - 2026 |
| Bancel Stephane | Director | filed 2026 - 2026 |
| Arnold Frances | Director | filed 2026 - 2026 |
| Mendillo Jane L | Director | filed 2026 - 2026 |
| Vessey Rupert | Director | filed 2026 - 2026 |
| Parker Paul Gray | Director | filed 2026 - 2026 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Martin Sean | Chief Legal Officer & GC | filed 2026 - 2026 |
| Grigoryan Gevorg | Chief Technology Officer | filed 2026 - 2026 |
| Silvers Jason | President & CFO | filed 2026 - 2026 |
| Grous Beth | Chief People Officer | filed 2026 - 2026 |
| Lee Laurie Anne | Chief Medical Officer | filed 2026 - 2026 |
| Khakoo Aarif | Chief Scientific Officer | filed 2026 - 2026 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.